About the role

Cardiometabolic Medical Science Liaison advancing Arrowhead Pharmaceuticals’ RNAi medicines. Engaging healthcare professionals, supporting trials, and communicating clinical science from Canada.

Responsibilities

Engage cardiologists, endocrinologists, and other healthcare professionals and stakeholders through scientific education and exchange.
Educate healthcare professionals on RNAi technology, hypertriglyceridemia, familial chylomicronemia syndrome, and hypercholesterolemia.
Synthesize and communicate clinical and scientific insights to internal stakeholders.
Attend and present at scientific congresses and meetings.
Respond to unsolicited inquiries in accordance with MSL compliance standards.
Support company-sponsored clinical trials through investigator site engagement.
Support speaker training and scientific congress activities, including opinion-leader engagement, session coverage, booth support, and debriefs.
Monitor and analyze scientific publications, clinical trials, and the competitive landscape in cardiometabolic therapeutics.
Maintain clinical, scientific, and industry business expertise.
Develop territory-specific opinion-leader and account plans.
Communicate clinical and scientific information accurately and clearly.
Document quantitative and qualitative accomplishments.
Provide scientific support for Medical Information inquiries.
Develop scientific content for medical education initiatives.
Build and manage cross-functional relationships.
Support Medical Affairs special projects and initiatives as needed.

PhD, PharmD, MD, or DO required.
Five or more years of experience as a Medical Science Liaison (MSL).
Experience in the cardiometabolic therapeutic area.
Medical Affairs industry experience at a biotechnology or pharmaceutical company.
Proficiency in Microsoft Office.
Experience with electronic CRM systems.
Fluent in English, written and spoken.
Ability to travel.
Current, valid authorization to work in the country where the role is located.